Bassam Jeryous Fares
Tracked across 1 events · 14 articles · First seen Jun 30, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Bassam Jeryous Fares is the first author of the systematic review, playing a key role in its execution and interpretation of the mixed findings regarding creatine's efficacy in treating depression.
Jun 30, 2026 · 14 articles
ERGEN INTELLIGENCE
Track Bassam Jeryous Fares live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard